Our Team

As the Senior Director: Patient Experience Data & Clinical Outcome Assessments in the Global Integrated Evidence & Innovation group at Otsuka Pharmaceutical and Development Corporation, David Bruhn and his team are responsible for broad research and operations-related activities within the R&D organization, supporting the full Otsuka pipeline, with a focus on neuroscience, digital and nephrology. Previously, he was Head of Health Economics & Outcomes Research (HEOR), Medical Affairs at Avanir Pharmaceuticals, where he was responsible for the early and timely translation of HEOR data for regulatory submissions, payer reimbursement and access. He applies HEOR data into evidence-based strategies, value messaging, customer facing tools, HTA, and formulary dossiers. Prior to joining Avanir, he was Executive Director of US Health Outcomes & Value at Allergan and Director of the US Regional Health Outcomes Liaisons at GlaxoSmithKline. In addition to working with large US payer organizations, he has designed and conducted health outcomes studies across multiple disease areas, with a focus in diabetes and neuroscience. He completed a 4-year term as an advisory panelist on the Patient Centered Outcomes Research Institute’s Improving Healthcare Systems Panel and provided BioPharma input into their program on comparative effectiveness research. He was previously a research advisor in the Global Health Outcomes organization at Lilly where he was responsible for the research and communication activities for exenatide. He was also an Outcomes Research Scientist supporting emerging and developed markets outside the US where his research centered on demonstrating value for diabetes therapeutics. As leader of the health outcomes liaison team, he partnered with large managed care organizations and state Medicaid as well as international government/HTA agencies on a variety of health outcomes research projects. Additionally, he helped develop several analytic tools to assist population health decision makers in understanding their medication utilization patterns and to improve medication efficiency and effectiveness. A biomedical-biochemical engineer by training, he completed a Doctor of Pharmacy and Master of Business Administration from USC. He enjoys time spent outdoors at his home in San Diego, CA with his wife and four children. Weekends are usually spent cheering on girls’ and boys’ water polo games, cooking and grilling in the backyard, and succulent yardwork and gardening.